Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats - Studies in the isolated perfused hydronephrotic kidney

Koichi Hayashi, Shu Wakino, Yuri Ozawa, Koichiro Honma, Takeshi Kanda, Ken Okubo, Ichiro Takamatsu, Satoru Tatematsu, Hiroo Kumagai, Takao Saruta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present study examined the role of L-/T-type Ca channels and the interaction between these channels and protein kinase C (PKC) in hypertension. The isolated perfused hydronephrotic rat kidney model was used to visualize directly the renal microvascular effects of L-/T-type Ca channel blockers (nifedipine and mibefradil, respectively). Nifedipine reversed the angiotensin II-induced constriction of afferent, but not efferent, arterioles in kidneys from Wistar-Kyoto rats (WKY), and similar magnitude in dilation was observed in spontaneously hypertensive rats (SHR). Although mibefradil elicited dilation of both arterioles, the afferent arteriolar dilation was less in SHR than in WKY (57 ±5% vs. 80 ± 4% reversal at 1 μmol/L). The pretreatment with staurosporine did not alter the angiotensin II-induced afferent arteriolar constriction in WKY, but attenuated this response in SHR. Furthermore, staurosporine enhanced the nifedipine-induced afferent arteriolar dilation (62 ± 3% vs. 50 ± 3% reversal at 10 nmol/L), and restored the attenuated afferent arteriolar response to mibefradil in SHR. The pretreatment with thapsigargin (a blocker of IP3-mediated intracellular calcium release) prevented the angiotensin II-induced afferent arteriolar constriction in WKY, but caused a significant constriction of afferent arterioles in SHR and efferent arterioles in WKY and SHR; in this setting, mibefradil did not alter efferent arteriolar tone. In conclusion, although both L-type (nifedipine) and T-type Ca channel blockers (mibefradil) exerted potent vasodilation of rat renal microvessels, these actions were modified by PKC, which determined the afferent arteriolar sensitivity to these blockers in SHR. Furthermore, the enhancement in nifedipine-induced afferent arteriolar dilation by staurosporine in SHR suggests that L-type Ca channel activity is augmented in hypertensive animals.

Original languageEnglish
Pages (from-to)102-108
Number of pages7
JournalKeio Journal of Medicine
Volume54
Issue number2
DOIs
Publication statusPublished - 2005 Jun

Fingerprint

Inbred SHR Rats
Mibefradil
Protein Kinase C
Dilatation
Inbred WKY Rats
Kidney
Nifedipine
Arterioles
Constriction
Staurosporine
Angiotensin II
Thapsigargin
Microvessels
Vasodilation
Hypertension
Calcium

Keywords

  • Afferent arterioles
  • Efferent arterioles
  • Hypertension
  • Mibefradil
  • Protein kinase C

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats - Studies in the isolated perfused hydronephrotic kidney. / Hayashi, Koichi; Wakino, Shu; Ozawa, Yuri; Honma, Koichiro; Kanda, Takeshi; Okubo, Ken; Takamatsu, Ichiro; Tatematsu, Satoru; Kumagai, Hiroo; Saruta, Takao.

In: Keio Journal of Medicine, Vol. 54, No. 2, 06.2005, p. 102-108.

Research output: Contribution to journalArticle

@article{7be187b48a0f4851954544e513217291,
title = "Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats - Studies in the isolated perfused hydronephrotic kidney",
abstract = "The present study examined the role of L-/T-type Ca channels and the interaction between these channels and protein kinase C (PKC) in hypertension. The isolated perfused hydronephrotic rat kidney model was used to visualize directly the renal microvascular effects of L-/T-type Ca channel blockers (nifedipine and mibefradil, respectively). Nifedipine reversed the angiotensin II-induced constriction of afferent, but not efferent, arterioles in kidneys from Wistar-Kyoto rats (WKY), and similar magnitude in dilation was observed in spontaneously hypertensive rats (SHR). Although mibefradil elicited dilation of both arterioles, the afferent arteriolar dilation was less in SHR than in WKY (57 ±5{\%} vs. 80 ± 4{\%} reversal at 1 μmol/L). The pretreatment with staurosporine did not alter the angiotensin II-induced afferent arteriolar constriction in WKY, but attenuated this response in SHR. Furthermore, staurosporine enhanced the nifedipine-induced afferent arteriolar dilation (62 ± 3{\%} vs. 50 ± 3{\%} reversal at 10 nmol/L), and restored the attenuated afferent arteriolar response to mibefradil in SHR. The pretreatment with thapsigargin (a blocker of IP3-mediated intracellular calcium release) prevented the angiotensin II-induced afferent arteriolar constriction in WKY, but caused a significant constriction of afferent arterioles in SHR and efferent arterioles in WKY and SHR; in this setting, mibefradil did not alter efferent arteriolar tone. In conclusion, although both L-type (nifedipine) and T-type Ca channel blockers (mibefradil) exerted potent vasodilation of rat renal microvessels, these actions were modified by PKC, which determined the afferent arteriolar sensitivity to these blockers in SHR. Furthermore, the enhancement in nifedipine-induced afferent arteriolar dilation by staurosporine in SHR suggests that L-type Ca channel activity is augmented in hypertensive animals.",
keywords = "Afferent arterioles, Efferent arterioles, Hypertension, Mibefradil, Protein kinase C",
author = "Koichi Hayashi and Shu Wakino and Yuri Ozawa and Koichiro Honma and Takeshi Kanda and Ken Okubo and Ichiro Takamatsu and Satoru Tatematsu and Hiroo Kumagai and Takao Saruta",
year = "2005",
month = "6",
doi = "10.2302/kjm.54.102",
language = "English",
volume = "54",
pages = "102--108",
journal = "Keio Journal of Medicine",
issn = "0022-9717",
publisher = "Keio University School of Medicine",
number = "2",

}

TY - JOUR

T1 - Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats - Studies in the isolated perfused hydronephrotic kidney

AU - Hayashi, Koichi

AU - Wakino, Shu

AU - Ozawa, Yuri

AU - Honma, Koichiro

AU - Kanda, Takeshi

AU - Okubo, Ken

AU - Takamatsu, Ichiro

AU - Tatematsu, Satoru

AU - Kumagai, Hiroo

AU - Saruta, Takao

PY - 2005/6

Y1 - 2005/6

N2 - The present study examined the role of L-/T-type Ca channels and the interaction between these channels and protein kinase C (PKC) in hypertension. The isolated perfused hydronephrotic rat kidney model was used to visualize directly the renal microvascular effects of L-/T-type Ca channel blockers (nifedipine and mibefradil, respectively). Nifedipine reversed the angiotensin II-induced constriction of afferent, but not efferent, arterioles in kidneys from Wistar-Kyoto rats (WKY), and similar magnitude in dilation was observed in spontaneously hypertensive rats (SHR). Although mibefradil elicited dilation of both arterioles, the afferent arteriolar dilation was less in SHR than in WKY (57 ±5% vs. 80 ± 4% reversal at 1 μmol/L). The pretreatment with staurosporine did not alter the angiotensin II-induced afferent arteriolar constriction in WKY, but attenuated this response in SHR. Furthermore, staurosporine enhanced the nifedipine-induced afferent arteriolar dilation (62 ± 3% vs. 50 ± 3% reversal at 10 nmol/L), and restored the attenuated afferent arteriolar response to mibefradil in SHR. The pretreatment with thapsigargin (a blocker of IP3-mediated intracellular calcium release) prevented the angiotensin II-induced afferent arteriolar constriction in WKY, but caused a significant constriction of afferent arterioles in SHR and efferent arterioles in WKY and SHR; in this setting, mibefradil did not alter efferent arteriolar tone. In conclusion, although both L-type (nifedipine) and T-type Ca channel blockers (mibefradil) exerted potent vasodilation of rat renal microvessels, these actions were modified by PKC, which determined the afferent arteriolar sensitivity to these blockers in SHR. Furthermore, the enhancement in nifedipine-induced afferent arteriolar dilation by staurosporine in SHR suggests that L-type Ca channel activity is augmented in hypertensive animals.

AB - The present study examined the role of L-/T-type Ca channels and the interaction between these channels and protein kinase C (PKC) in hypertension. The isolated perfused hydronephrotic rat kidney model was used to visualize directly the renal microvascular effects of L-/T-type Ca channel blockers (nifedipine and mibefradil, respectively). Nifedipine reversed the angiotensin II-induced constriction of afferent, but not efferent, arterioles in kidneys from Wistar-Kyoto rats (WKY), and similar magnitude in dilation was observed in spontaneously hypertensive rats (SHR). Although mibefradil elicited dilation of both arterioles, the afferent arteriolar dilation was less in SHR than in WKY (57 ±5% vs. 80 ± 4% reversal at 1 μmol/L). The pretreatment with staurosporine did not alter the angiotensin II-induced afferent arteriolar constriction in WKY, but attenuated this response in SHR. Furthermore, staurosporine enhanced the nifedipine-induced afferent arteriolar dilation (62 ± 3% vs. 50 ± 3% reversal at 10 nmol/L), and restored the attenuated afferent arteriolar response to mibefradil in SHR. The pretreatment with thapsigargin (a blocker of IP3-mediated intracellular calcium release) prevented the angiotensin II-induced afferent arteriolar constriction in WKY, but caused a significant constriction of afferent arterioles in SHR and efferent arterioles in WKY and SHR; in this setting, mibefradil did not alter efferent arteriolar tone. In conclusion, although both L-type (nifedipine) and T-type Ca channel blockers (mibefradil) exerted potent vasodilation of rat renal microvessels, these actions were modified by PKC, which determined the afferent arteriolar sensitivity to these blockers in SHR. Furthermore, the enhancement in nifedipine-induced afferent arteriolar dilation by staurosporine in SHR suggests that L-type Ca channel activity is augmented in hypertensive animals.

KW - Afferent arterioles

KW - Efferent arterioles

KW - Hypertension

KW - Mibefradil

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=21744437721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744437721&partnerID=8YFLogxK

U2 - 10.2302/kjm.54.102

DO - 10.2302/kjm.54.102

M3 - Article

C2 - 16077260

AN - SCOPUS:21744437721

VL - 54

SP - 102

EP - 108

JO - Keio Journal of Medicine

JF - Keio Journal of Medicine

SN - 0022-9717

IS - 2

ER -